{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:24:24Z","timestamp":1793881464656,"version":"4.7.0"},"reference-count":50,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijdvl.ijdvl_769_19","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T12:14:25Z","timestamp":1603800865000},"page":"611","source":"Crossref","is-referenced-by-count":15,"title":["Rosacea in skin of color: A comprehensive review"],"prefix":"10.25259","volume":"86","author":[{"given":"Rashmi","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrashis","family":"Podder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.299277-1","doi-asserted-by":"crossref","unstructured":"Berth-Jones J. Rosacea, perioral dermatitis and similar dermatoses, flushing and flushing syndromes. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 7th ed.. UK: Wiley-Blackwell Publishing Ltd.; 2004. p. 2197-216.","DOI":"10.1002\/9780470750520.ch44"},{"key":"key-10.4103\/0378-6323.299277-2","first-page":"13030","volume-title":"Rosacea in skin of color: Not a rare diagnosis","author":"Al-Dabagh","year":"2014","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/0378-6323.299277-3","first-page":"30","volume-title":"Steroid-induced rosacea: A clinical study of 200 patients","author":"Bhat","year":"2011","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/0378-6323.299277-4","first-page":"234","volume-title":"Rosacea and rhinophyma: Not curse of the Celts but Indo Eurasians","author":"Wollina","year":"2009","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/0378-6323.299277-5","first-page":"321","volume-title":"Unusual features of rosacea in Saudi females with dark skin","author":"Al","year":"2014","journal-title":"Ochsner J"},{"key":"key-10.4103\/0378-6323.299277-6","first-page":"1548","volume-title":"Assessment of the genetic basis of rosacea by genome-wide association study","author":"Chang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.299277-7","first-page":"597","volume-title":"Rosacea: 244 Tunisian cases","author":"Khaled","year":"2010","journal-title":"Tunis Med"},{"key":"key-10.4103\/0378-6323.299277-8","first-page":"323","volume-title":"Skin diseases in Ghana and the UK","author":"Doe","year":"2001","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-9","first-page":"1213","volume-title":"Genetic vs.environmental factors that correlate with rosacea: A cohort-based survey of twins","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"key-10.4103\/0378-6323.299277-10","first-page":"S15","volume-title":"New insights into rosacea pathophysiology: A review of recent findings","author":"Steinhoff","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-11","first-page":"748","volume-title":"Lymphangiogenesis and angiogenesis in non-phymatous rosacea","author":"Gomaa","year":"2007","journal-title":"J Cutan Pathol"},{"key":"key-10.4103\/0378-6323.299277-12","first-page":"77","volume-title":"The molecular pathology of rosacea","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.299277-13","first-page":"67","volume-title":"Are Demodex mites principal, conspirator, accomplice, witness or bystander in the cause of rosacea?","author":"Chen","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0378-6323.299277-14","first-page":"305","volume-title":"Rosacea and & Helicobacter pylori: Links and risks","author":"Lazaridou","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key-10.4103\/0378-6323.299277-15","first-page":"975","volume-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"key-10.4103\/0378-6323.299277-16","first-page":"1253","volume-title":"Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea","author":"Sulk","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.299277-17","first-page":"907","volume-title":"Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-18","first-page":"243","volume-title":"Clinical evaluation of 168 Korean patients with rosacea: The sun exposure correlates with the erythematotelangiectatic subtype","author":"Bae","year":"2009","journal-title":"Ann Dermatol"},{"key":"key-10.4103\/0378-6323.299277-19","first-page":"e3527","volume-title":"An observational descriptive survey of rosacea in the Chinese population: Clinical features based on the affected locations","author":"Xie","year":"2017","journal-title":"PeerJ"},{"key":"key-10.4103\/0378-6323.299277-20","first-page":"35","volume-title":"Rhinophyma in Japan","author":"Furukawa","year":"1994","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-21","first-page":"100","volume-title":"Rosacea and gastrointestinal disorders: A population-based cohort study","author":"Egeberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-22","first-page":"911","volume-title":"Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-23","first-page":"598","volume-title":"A study on the epidemiology of rosacea in the UK","author":"Spoendlin","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-24","first-page":"249","volume-title":"Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan","author":"Hua","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-25","first-page":"921","volume-title":"Patients with rosacea have increased risk of dementia","author":"Egeberg","year":"2016","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0378-6323.299277-26","first-page":"761","volume-title":"Rosacea: Part II.Topical and systemic therapies in the treatment of rosacea","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-27","first-page":"213","volume-title":"Cosmeceuticals for rosacea","author":"Draelos","year":"2017","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/0378-6323.299277-28","first-page":"570","volume-title":"Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel","author":"Coda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-29","first-page":"760","volume-title":"Effective and evidence-based management strategies for rosacea: Summary of a Cochrane systematic review","author":"van","year":"2011","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-30","first-page":"1125","volume-title":"Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system","author":"Narayanan","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"key-10.4103\/0378-6323.299277-31","first-page":"679","volume-title":"Topical metronidazole maintains remissions of rosacea","author":"Dahl","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0378-6323.299277-32","first-page":"633","volume-title":"Once-daily topical brimonidine tartrate gel 0\u00b75% is a novel treatment for moderate to severe facial erythema of rosacea: Results of two multicentre, randomized and vehicle-controlled studies","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-33","first-page":"650","volume-title":"Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: Results of two randomized, double-blind, and vehicle-controlled pivotal studies","author":"Fowler","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.299277-34","first-page":"71","volume-title":"New developments in the treatment of rosacea-role of once-daily ivermectin cream","author":"Cardwell","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key-10.4103\/0378-6323.299277-35","first-page":"1103","volume-title":"Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: A randomized, investigator-blinded trial","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-36","first-page":"207","volume-title":"Pharmacologic treatments for rosacea","author":"Layton","year":"2017","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/0378-6323.299277-37","doi-asserted-by":"crossref","unstructured":"Rebora A, Drago F. Papulopustular rosacea. In: Williams CH, editor. Evidence-Based Dermatology. 3rd ed.. UK: Wiley Blackwell; 2017. p. 106-11.","DOI":"10.1002\/9781118357606.ch20"},{"key":"key-10.4103\/0378-6323.299277-38","first-page":"703","volume-title":"Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender","author":"Del","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0378-6323.299277-39","first-page":"881","volume-title":"Symptomatic treatment of idiopathic and rosacea-associated cutaneous flushing with propranolol","author":"Craige","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299277-40","first-page":"505","volume-title":"Systemic isotretinoin in the treatment of rosacea-doxycycline- and placebo-controlled, randomized clinical study","author":"Gollnick","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"key-10.4103\/0378-6323.299277-41","first-page":"318","volume-title":"Relationship between Helicobacter pylori and Rosacea: review and discussion","author":"Yang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/0378-6323.299277-42","first-page":"777","volume-title":"Helicobacter pylori and its eradication in rosacea","author":"Szlachcic","year":"1999","journal-title":"J Physiol Pharmacol"},{"key":"key-10.4103\/0378-6323.299277-43","first-page":"249","volume-title":"Incidental control of rosacea by somatostatin","author":"Pi\u00e9rard-Franchimont","year":"2003","journal-title":"Dermatology"},{"key":"key-10.4103\/0378-6323.299277-44","first-page":"857","volume-title":"Oral zinc sulphate in the treatment of rosacea: A double blind placebo controlled study","author":"Sharique","year":"2006","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-45","first-page":"459","volume-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.299277-46","first-page":"134","volume-title":"American Acne & Rosacea Society.Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea","author":"Del","year":"2014","journal-title":"Cutis"},{"key":"key-10.4103\/0378-6323.299277-47","doi-asserted-by":"crossref","unstructured":"Tanghetti EA, Mirkov M, Sierra RA. Common vascular lesions. In: Raulin C, Karsai S, editors. Laser and IPL Technology in Dermatology and Aesthetic Medicine. Berlin, Germany: Springer-Verlag Berlin Heidelberg; 2011. p. 227-40.","DOI":"10.1007\/978-3-642-03438-1_16"},{"key":"key-10.4103\/0378-6323.299277-48","first-page":"1143","volume-title":"Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor","author":"Two","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.299277-49","first-page":"2728","volume-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.299277-50","first-page":"431","volume-title":"Updating the diagnosis, classification and assessment of rosacea: Recommendations from the global ROSacea COnsensus (ROSCO) panel","author":"Tan","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:40:51Z","timestamp":1611916851000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/rosacea-in-skin-of-color-a-comprehensive-review\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["299277"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_769_19","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}